Cargando…
Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy
Inflammatory bowel diseases (IBD) are chronic disorders of the gastrointestinal tract that have been linked to microbiome dysbiosis and immune system dysregulation. We investigated the longitudinal effect of anti-TNF therapy on gut microbiota composition and specific immune response to commensals in...
Autores principales: | Schierova, Dagmar, Roubalova, Radka, Kolar, Martin, Stehlikova, Zuzana, Rob, Filip, Jackova, Zuzana, Coufal, Stepan, Thon, Tomas, Mihula, Martin, Modrak, Martin, Kverka, Miloslav, Bajer, Lukas, Kostovcikova, Klara, Drastich, Pavel, Hercogova, Jana, Novakova, Michaela, Vasatko, Martin, Lukas, Milan, Tlaskalova-Hogenova, Helena, Jiraskova Zakostelska, Zuzana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617723/ https://www.ncbi.nlm.nih.gov/pubmed/34831411 http://dx.doi.org/10.3390/cells10113188 |
Ejemplares similares
-
Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: A pilot study
por: Rob, Filip, et al.
Publicado: (2022) -
Serum TGF-β1 and CD14 Predicts Response to Anti-TNF-α Therapy in IBD
por: Coufal, Stepan, et al.
Publicado: (2023) -
Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy
por: Reiss, Zuzana, et al.
Publicado: (2023) -
Inflammatory Bowel Disease Types Differ in Markers of Inflammation, Gut Barrier and in Specific Anti-Bacterial Response
por: Coufal, Stepan, et al.
Publicado: (2019) -
Dysbiosis of Skin Microbiota in Psoriatic Patients: Co-occurrence of Fungal and Bacterial Communities
por: Stehlikova, Zuzana, et al.
Publicado: (2019)